Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Modeled economic evaluation of alternative strategies to reduce sudden cardiac death among children treated for attention deficit/hyperactivity disorder.

Denchev P, Kaltman JR, Schoenbaum M, Vitiello B.

Circulation. 2010 Mar 23;121(11):1329-37. doi: 10.1161/CIRCULATIONAHA.109.901256. Epub 2010 Mar 8.

2.

Prediction and prevention of sudden death in young populations: the role of ECG screening.

Dougherty KR, Friedman RA, Link MS, Estes NA 3rd.

J Interv Card Electrophysiol. 2013 Mar;36(2):167-75. doi: 10.1007/s10840-012-9755-5. Epub 2012 Nov 21. Review.

PMID:
23179925
3.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

4.

Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.

Corrado D, Pelliccia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, Panhuyzen-Goedkoop N, Deligiannis A, Solberg E, Dugmore D, Mellwig KP, Assanelli D, Delise P, van-Buuren F, Anastasakis A, Heidbuchel H, Hoffmann E, Fagard R, Priori SG, Basso C, Arbustini E, Blomstrom-Lundqvist C, McKenna WJ, Thiene G; Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.

Eur Heart J. 2005 Mar;26(5):516-24. Epub 2005 Feb 2. Review.

PMID:
15689345
5.

Sudden cardiac death in athletes.

Schmied C, Borjesson M.

J Intern Med. 2014 Feb;275(2):93-103. doi: 10.1111/joim.12184. Review.

6.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

7.

Contemporary approaches to the identification of athletes at risk for sudden cardiac death.

Drezner JA.

Curr Opin Cardiol. 2008 Sep;23(5):494-501. doi: 10.1097/HCO.0b013e32830b3624. Review.

PMID:
18670262
8.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
9.

Sudden cardiac death in athletes: what is the role of screening?

Corrado D, Basso C, Thiene G.

Curr Opin Cardiol. 2012 Jan;27(1):41-8. doi: 10.1097/HCO.0b013e32834dc4cb. Review.

PMID:
22139701
10.

[Cardiac screening of young athletes].

Stokstad MT, Berge HM, Gjesdal K.

Tidsskr Nor Laegeforen. 2013 Sep 3;133(16):1722-5. doi: 10.4045/tidsskr.13.0016. Review. Norwegian.

11.

[Cardiovascular risk assessment for the use of ADHD drugs in children].

Berg A, Bråtane E, Odland HH, Brudvik C, Rosland B, Hirth A.

Tidsskr Nor Laegeforen. 2014 Apr 8;134(7):710-4. doi: 10.4045/tidsskr.13.0565. eCollection 2014 Apr 8. Review. Norwegian.

12.

Preparticipation screening and prevention of sudden cardiac death in athletes: implications for primary care.

Morse E, Funk M.

J Am Acad Nurse Pract. 2012 Feb;24(2):63-9. doi: 10.1111/j.1745-7599.2011.00694.x. Epub 2012 Jan 30. Review.

PMID:
22324860
13.

Sudden death in athletes: an update.

Futterman LG, Myerburg R.

Sports Med. 1998 Nov;26(5):335-50. Review.

PMID:
9858396
14.

Sudden death screening.

Rich BS.

Med Clin North Am. 1994 Mar;78(2):267-88. Review.

PMID:
8121211
15.

Stimulants and sudden death: what is a physician to do?

Wilens TE, Prince JB, Spencer TJ, Biederman J.

Pediatrics. 2006 Sep;118(3):1215-9. Review.

PMID:
16951018
16.

Expert opinion and controversies in musculoskeletal and sports medicine: preventing sudden cardiac death in young athletes.

Rao AL, Standaert CJ, Drezner JA, Herring SA.

Arch Phys Med Rehabil. 2010 Jun;91(6):958-62. doi: 10.1016/j.apmr.2010.02.006. Review.

PMID:
20510990
17.

Sudden cardiac death in young athletes: what is the role of screening?

Asif IM, Rao AL, Drezner JA.

Curr Opin Cardiol. 2013 Jan;28(1):55-62. doi: 10.1097/HCO.0b013e32835b0ab9. Review.

PMID:
23196775
18.

Sudden cardiac death and preparticipation screening: the debate continues-in support of electrocardiogram-inclusive preparticipation screening.

Asif IM, Drezner JA.

Prog Cardiovasc Dis. 2012 Mar-Apr;54(5):445-50. doi: 10.1016/j.pcad.2012.01.001. Review.

PMID:
22386296
19.

Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent Psychiatry.

Warren AE, Hamilton RM, Bélanger SA, Gray C, Gow RM, Sanatani S, Côté JM, Lougheed J, LeBlanc J, Martin S, Miles B, Mitchell C, Gorman DA, Weiss M, Schachar R.

Can J Cardiol. 2009 Nov;25(11):625-30. Review.

20.

Sudden cardiac death in infants, children, and adolescents.

Berger S, Dhala A, Friedberg DZ.

Pediatr Clin North Am. 1999 Apr;46(2):221-34. Review.

PMID:
10218071

Supplemental Content

Support Center